News

Filter

Current filters:

Otsukadelamanid

Janssen-Cilag files for EU approval of bedaquiline in MDR-TB

02-09-2012

Johnson & Johnson (NYSE: JNJ) Belgium-based subsidiary Janssen-Cilag International submitted a Marketing…

Antibiotics and Infectious diseasesbedaquilinedelamanidEuropeJanssen-CilagJohnson & JohnsonOtsukaPharmaceuticalRegulation

Positive Ph IIb results for Otsuka TB drug candidate delamanid

07-06-2012

Japanese drugmaker Otsuka Pharmaceutical (TYO: 4578) has announced Phase IIb clinical trial results on…

Antibiotics and Infectious diseasesdelamanidOtsukaPharmaceuticalResearchRespiratory and Pulmonary

COMPANY SPOTLIGHT

Menarini

Back to top